Search bioRxiv⌕ Search

Biology subjects

Andrades, E.

Publications and source records attributed to Andrades, E..

3 recordsLinked to original sources

PHYSICOCHEMICAL PROPERTIES OF ENHANCED AND RECOVERED VENEZUELAN CRUDE OIL TREATED WITH BIOCOMPATIBLE PHARMACEUTICAL FORMULATION: SIMULATION OF THE ROLE OF WATER AND IONIC CONTENT.

In this work, the hydrogen bonding interaction of water and ethanol with Polysorbate 80 (P-80, Tween 80) is simulated, in relation to its role in oil upgrading and recovery, using real theoretical and experimental studies. The theoretical physicochemical results obtained were compared with other experimental results derived from the treatment of improved and recovered oil after mixing Biocompatible Pharmaceutical Formulations (BPF) of these three compounds and oil produced in Venezuela. The Spartan 16 program was used to build the molecular structures and simulate the interactions with the semi-empirical PM3 method, to compare them with two real experiments. These two experiments were performed as follows: in the first, the mixture consists of a surfactant, (Z)-Sorbitan mono-9-octadecenoate poly(oxy-1,2-ethanediyl) or polyoxoethylene (20) sorbitan mono-oleate (Polysorbate 80), which is mixed with the hydrocarbon, and then completely fluidized with the addition of ethyl alcohol or ethanol.Water and ions (<100 ppm) present in this experiment are contained in oil and ethanol as contaminants (approximately 1.73-1.30% of total water). In the second experiment, the BPF ratios were 10:5:0.1:0.01 for oil:water with 17,800 ppm NaCl:P-80:ethanol (approximately 33.09% of total water and 1.78% w/v NaCl). The simulations were performed taking into account both real experiments. The simulated interactive products were characterized by the following parameters: energy, minimum conformational energy, solvation energy, aqueous energy, HOMO energy, LUMO energy, {Delta}E, dipole moment, polarizability, electrostatic potential map (EPM) and electron density.A theoretical parametric relationship (sio Index, "stability in oil Index") is developed to evaluate the stability of the molecular forms generated within the hydrocarbon. The following theoretical experiments were performed: First, successive interactions of water with P-80 from position 1 to position 21. Second, successive interactions from position 1 to position 21 of P-80 of water and ethanol, 1 to 1. Third, successive interactions with P-80 of 21 ethanol molecules on the final product of the first experiment. These theoretical results were compared with some experimental results obtained using Oil Mixtures. The results obtained and compared in both experimental series (theoretical and real) allow to distinguish the role of P-80, Ethanol, Water and ions for the improvement and recovery of the treated oil. It is concluded that the formulation that does not contain added water and sodium chloride is supposed to use the contaminating water present in the petroleum and the water contained in the ethanol (<5%).This formulation has very little effect on the resulting Density of the improved Oil, but it greatly decreases the resulting Viscosity in the Crude Oil. The formulation that contains more than 30% added Water decreases the Density while the Viscosity of the Crude Oil responds proportionally to the Water retained in it. This difference in the results could be interpreted as a different proportion and chemical composition as a consequence of a different structural relationship between these components and a different conformation of the nanoparticle generated within the Oil, in each case. In this sense, the hypothesis is established that there would be an intermediate molecular form that could improve both Viscosity and Density.

biophysics↗

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived SS cells

Structured AbstractO_ST_ABSBackgroundC_ST_ABSEradication of SS is hampered by its genetic and molecular heterogeneity. A better understanding of the putative commonalities underlying SS oncogenicity may help to provide more efficient therapeutic strategies against this devastating disease. PurposeThe present work analyzes the whole transcriptome of different patient-derived SS cells to identify expression patterns, functional programs and expressed gene mutations that may provide clues on new therapeutic options for SS patients MethodsMononuclear cells were recovered by Ficoll gradient separation from fresh peripheral blood of SS patients (n=7). Selected pathway-based compounds and the MALT1 inhibitor MI2 were used for in vitro drug sensitivity testing. SS cells viability was evaluated using CellTiter-Glo_3D Cell Viability Assay and flow cytometry analysis. We validated the usefulness of MI2 using patient-derived SS cells xenotransplanted (PDX) into Nod Scid Gamma mice. ResultsIn vitro data indicated that cell lines and primary malignant SS cells all display different sensitivities against specific pathway inhibitors. However, MALT1 inhibition led to a robust effect in vitro that was partially reproduced in the in vivo NSG mice xenograft model. ConclusionOur investigations revealed the actual possibility of inhibiting the downstream TCR signaling complex form by CARD11, BCL10 and MALT1 in SS therapy. Key PointsPatient-derived SS cells are transcriptionally and mutationally heterogeneous but share some common pathway alterations. Inhibition of MALT1 reduces NF-{kappa}B signaling and cell growth in cell lines and patient-derived SS cells.

cancer biology↗

EWS-FLI1 Expression in Human Embryonic MSCs Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma

Ewing sarcoma (ES) is an aggressive bone and soft tissue neoplasm characterized by EWSR1/ETS rearrangements and whose cellular origin remains unclear. EWS-FLI1 expression in human pediatric mesenchymal stem cells (hpMSCs) induces a quantitatively and qualitatively different transcriptional response than its expression in human adult MSCs (haMSCs), but fails to form tumors in vivo. ES cells have early developmental lineage signatures distinct from postnatal MSCs. Here, we have generated MSCs from experimental teratomas out of human embryonic stem cells (heSCs). Transduction of these human embryonic mesenchymal stem cells (heMSCs) with EWS-FLI1 results in the acquisition of an ES transcriptome, although the oncogene does not preferentially bind to promoters, but to intronic and intergenic microsatellites with >10 CA dinucleotides and GGAA repeats, respectively. In heMSCs, EWS-FLI1 directly regulates BRCA1 expression, although EWS-FLI1-expressing cells show defects in DNA damage repair. Xenografting of EWS-FLI1-transduced heMSCs resulted in the formation of tumors expressing characteristic ES markers. In summary, EWS-FLI1 enforces an aberrant transcriptome and endows in vivo transforming capacity when expressed in an undifferentiated early heMSC. Our approach represents an innovative experimental method for understanding critical aspects of the biology of developmental tumors, from leukemia to sarcomas, in which few (even single) genetic alterations are able to transform a fetal stem cell.

cancer biology↗